购物车

搜索结果

Search Results for " labetuzumab "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T9901A-004 Labetuzumab

IMMU-14,hMN-14,IMMU-100

Labetuzumab (hMN-14) 是一种人源化抗癌胚抗原 (CEA) 单克隆抗体,具有抗癌活性,可抑制肿瘤生长,可用于研究甲状腺癌和结直肠癌 (CRC)。
T25593 Labetuzumab govitecan

IMMU-130,Labetuzumab-SN38,hMN14-SN38,IMMU130,IMMU 130

Others Others
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
T17732 CL2A

Others Others
CL2A is a pH-sensitive, cleavable PEG8- and triazole-containing PABC-peptide-mc linker, characterized by its ability to induce a bystander effect. It forms a disulfide bond with an antibody at a cysteine residue. Labetuzumab govitecan utilizes this linker for its drug conjugation[1].

化合物

Labetuzumab
Cat.No: T9901A-004
Synonym: IMMU-14,hMN-14,IMMU-100
Target:
Labetuzumab govitecan
Cat.No: T25593
Synonym: IMMU-130,Labetuzumab-SN38,hMN14-SN38,IMMU130,IMMU 130
Target: Others
CL2A
Cat.No: T17732
Synonym:
Target: Others
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼